Abiomed Announces Expanded Heart Recovery Strategy with Multi Year Growth Initiatives

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today presented its expanded heart recovery strategy along with new initiatives that are expected to enhance strong, multi-year double digit sales and earnings growth. During its annual investor and analyst day in New York City, Abiomed will discuss the recently announced PROTECT II clinical and economic developments, the new Symphony™ product, the Company’s strategy for long term growth and its new technology pipeline.